MX2016013280A - Composiciones topicas para el alivio del dolor, manufactura y uso. - Google Patents

Composiciones topicas para el alivio del dolor, manufactura y uso.

Info

Publication number
MX2016013280A
MX2016013280A MX2016013280A MX2016013280A MX2016013280A MX 2016013280 A MX2016013280 A MX 2016013280A MX 2016013280 A MX2016013280 A MX 2016013280A MX 2016013280 A MX2016013280 A MX 2016013280A MX 2016013280 A MX2016013280 A MX 2016013280A
Authority
MX
Mexico
Prior art keywords
manufacture
pain relief
topical compositions
methods
compositions
Prior art date
Application number
MX2016013280A
Other languages
English (en)
Inventor
Daniel Bucks
J Birbara Philip
Original Assignee
Vizuri Health Sciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vizuri Health Sciences Llc filed Critical Vizuri Health Sciences Llc
Publication of MX2016013280A publication Critical patent/MX2016013280A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a composiciones agonistas selectivas de TRPV1 que incluyen un capsaicinoide, un surfactante y un agente de liberación prolongada, y a métodos de manufactura y métodos para proporcionar alivio del dolor así como también para tratar una variedad de trastornos con estas composiciones.
MX2016013280A 2014-04-15 2015-04-15 Composiciones topicas para el alivio del dolor, manufactura y uso. MX2016013280A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461979905P 2014-04-15 2014-04-15
PCT/US2015/025957 WO2015160941A1 (en) 2014-04-15 2015-04-15 Topical compositions for pain relief, manufacture and use

Publications (1)

Publication Number Publication Date
MX2016013280A true MX2016013280A (es) 2017-04-27

Family

ID=53008908

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016013280A MX2016013280A (es) 2014-04-15 2015-04-15 Composiciones topicas para el alivio del dolor, manufactura y uso.

Country Status (9)

Country Link
US (6) US9956190B2 (es)
EP (1) EP3131531B1 (es)
JP (1) JP6563954B2 (es)
KR (1) KR102073258B1 (es)
AU (1) AU2015247649B2 (es)
BR (1) BR112016023815A2 (es)
CA (1) CA2945818C (es)
MX (1) MX2016013280A (es)
WO (1) WO2015160941A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2893768C (en) 2012-12-07 2021-08-24 Sambria Pharmaceuticals, Llc Topical preparation for pain relief
US10265283B2 (en) 2012-12-07 2019-04-23 Sambria Pharmaceuticals, Llc Topical composition and delivery system and its use
WO2015160941A1 (en) * 2014-04-15 2015-10-22 Vizuri Health Sciences Llc Topical compositions for pain relief, manufacture and use
GB2600651A (en) * 2016-02-03 2022-05-04 Sbg Medical Tech Inc Topical composition and delivery system and its use
KR102657458B1 (ko) 2016-11-02 2024-04-12 센트렉시온 테라퓨틱스 코포레이션 안정한 수성의 캡사이신 주사 가능한 제형 및 이의 의학적 용도
US10918685B2 (en) * 2017-01-05 2021-02-16 Ravi Ramamoorthy Iyer Herbal topical composition for muscle and joint health, recovery from exertion, and for pain management
GB201709141D0 (en) 2017-06-08 2017-07-26 Klaria Pharma Holding Ab Pharmaceutical formulation
AU2018302342B2 (en) 2017-07-20 2024-08-08 Centrexion Therapeutics Corporation Methods and compositions for treatment of pain using capsaicin
GB201808462D0 (en) 2018-05-23 2018-07-11 Klaria Pharma Holding Ab Pharmaceutical formulation
US11254659B1 (en) 2019-01-18 2022-02-22 Centrexion Therapeutics Corporation Capsaicinoid prodrug compounds and their use in treating medical conditions
US11447444B1 (en) 2019-01-18 2022-09-20 Centrexion Therapeutics Corporation Capsaicinoid prodrug compounds and their use in treating medical conditions
JP2020152674A (ja) * 2019-03-20 2020-09-24 株式会社リコー 難水溶性化合物の可溶化物の製造方法
JP2023517745A (ja) 2020-03-17 2023-04-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 初期非応答者を治療するためのカプサイシンパッチの繰り返しの局所適用
KR20220164022A (ko) 2020-04-03 2022-12-12 그뤼넨탈 게엠베하 캡사이신 패치의 반복된 국소 적용 요법
US20230210809A9 (en) * 2020-10-03 2023-07-06 Pruvyc Pharma, LLC Method for Treating Pruritus
KR102567166B1 (ko) * 2022-01-18 2023-08-18 주식회사 네오메디컬 스틱형 파스

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486450B1 (en) 1980-07-14 1998-07-28 Joel E Bernstein Method of treating psoriatic skin and composition
US4424205A (en) 1982-03-18 1984-01-03 The Procter & Gamble Company Hydroxyphenylacetamides having analgesic and anti-irritant activity
US4997853A (en) 1988-12-02 1991-03-05 Galenpharma, Inc. Method and compositions utilizing capsaicin as an external analgesic
US5134166A (en) 1988-12-02 1992-07-28 Genderm Corporation Method for treating nasal disorders and headaches
US5178879A (en) 1992-04-17 1993-01-12 Michael Adekunle Capsaicin gel
US5910512A (en) 1994-04-18 1999-06-08 Healthline Laboratories, Inc. Topical analgesic using water soluble capsaicin
US5560910A (en) 1994-08-26 1996-10-01 Crandall; Wilson T. Topical anti-inflammatory composition and method
US6239180B1 (en) 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
CA2285203C (en) 1997-03-13 2005-07-26 James N. Campbell Compositions containing capsaicin or capsaicin analogues and a local anesthetic
JP3211027B2 (ja) * 1998-11-13 2001-09-25 丸石製薬株式会社 カプサイシン含有外用剤
US6573302B1 (en) 1999-09-29 2003-06-03 Medical Merchandising, Inc. Cream utilizing capsaicin
US6348501B1 (en) 1999-09-29 2002-02-19 Medical Merchandising, Inc. Lotion compositions utilizing capsaicin
US6689399B1 (en) 2000-03-16 2004-02-10 James R. Dickson Transdermal delivery of an anti-inflammatory composition
AU2003299691B2 (en) 2002-12-18 2008-06-05 Algorx Pharmaceuticals, Inc. Administration of capsaicinoids
EP2907503A1 (en) 2003-04-10 2015-08-19 Neurogesx, Inc. Methods and compositions for administration of TRPV1 agonists
JP5148271B2 (ja) 2004-06-02 2013-02-20 ニューロジズエックス，インコーポレーテッド 疼痛処置のためのカプサイシノイド、局所麻酔薬および／または鎮痒薬を含有する処方物
CN101119713A (zh) 2004-11-24 2008-02-06 阿尔高克斯制药公司 类辣椒素凝胶制剂及其用途
DK1830835T3 (da) * 2004-12-28 2012-07-02 Mestex Ag Anvendelse af en vanilloid receptorantagonist sammen med et glycosaminoglycan eller proteoglycan til fremstilling af et middel til behandling af smerter
WO2006107723A1 (en) 2005-04-01 2006-10-12 Neurogesx, Inc. Oils of capsaicinoids and methods of making and using the same
BRPI0610333A2 (pt) 2005-04-25 2010-06-15 Neurogesx Inc compostos agonistas de trpv1 e métodos de fazer e usar os mesmos
JP5319278B2 (ja) 2005-05-27 2013-10-16 ロイヤー バイオメディカル， インク． 生体再吸収性ポリマーマトリックス、ならびにその作製および使用方法
JP5066342B2 (ja) * 2006-04-28 2012-11-07 キユーピー株式会社 新規なヒアルロン酸および／またはその塩、ならびにこれを用いた化粧料、医薬組成物、食品組成物、および化粧料キット
US7282224B1 (en) * 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
US7943666B2 (en) 2006-07-24 2011-05-17 Trinity Laboratories, Inc. Esters of capsaicin for treating pain
EP2316420B1 (en) * 2009-10-22 2014-02-26 Consorzio Universitario Unifarm Topical ophthalmic composition to reduce pain
US8637569B2 (en) 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
WO2011057387A1 (en) * 2009-11-13 2011-05-19 Oral Delivery Technology Ltd . Nitric oxide amino acid esters for the treatment of chronic pain
PT2455066T (pt) 2010-11-08 2018-12-06 Epitech Group S P A Preparação farmacológica para utilização tópica contendo n-palmitoil-vanilamida
EP2753319B1 (en) 2011-09-09 2018-04-11 Vizuri Health Sciences LLC A pain relief composition, comprising a trpv1 selective agonist, and manufacture and uses thereof
CN105101949A (zh) * 2012-11-12 2015-11-25 Api起源有限责任公司 水基辣椒素类物质制剂及其制备方法和应用
WO2015160941A1 (en) 2014-04-15 2015-10-22 Vizuri Health Sciences Llc Topical compositions for pain relief, manufacture and use

Also Published As

Publication number Publication date
US20180214398A1 (en) 2018-08-02
US10085956B2 (en) 2018-10-02
JP2017511366A (ja) 2017-04-20
US10583100B2 (en) 2020-03-10
KR20160145628A (ko) 2016-12-20
US20200323800A1 (en) 2020-10-15
AU2015247649A1 (en) 2016-11-03
KR102073258B1 (ko) 2020-02-04
US20150290151A1 (en) 2015-10-15
CA2945818C (en) 2022-05-03
US11123315B2 (en) 2021-09-21
CA2945818A1 (en) 2015-10-22
EP3131531A1 (en) 2017-02-22
US11737994B2 (en) 2023-08-29
US20180214397A1 (en) 2018-08-02
US9956190B2 (en) 2018-05-01
US10206892B2 (en) 2019-02-19
BR112016023815A2 (pt) 2017-08-15
AU2015247649B2 (en) 2019-01-17
EP3131531B1 (en) 2022-04-06
US20220168247A1 (en) 2022-06-02
JP6563954B2 (ja) 2019-08-21
US20190247337A1 (en) 2019-08-15
WO2015160941A1 (en) 2015-10-22

Similar Documents

Publication Publication Date Title
MX2016013280A (es) Composiciones topicas para el alivio del dolor, manufactura y uso.
ZA201708692B (en) Antibacterial compounds
MX2023008686A (es) Polinucleotidos moduladores.
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
IL255615A (en) Use of cannabis to treat fibromyalgia, methods and compositions thereof
MX2021008376A (es) Cultivo, produccion, procesamiento y uso de cannabis de especialidad.
MX2017005457A (es) Metodos y compuestos agonistas de gip.
MX2016003843A (es) Inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y usos de los mismos.
NZ720769A (en) Anti-siglec-8 antibodies and methods of use thereof
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
MX2018006700A (es) Inhibidores aza-bencimidazol de peptidilarginina desiminasa (pad4).
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
MX2017008414A (es) Composiciones inhibidoras de nitrificacion y metodos para preparar las mismas.
MX370412B (es) Compuesto antimicotico.
SG10202013034QA (en) Compositions, devices, and methods for the treatment of alcohol use disorder
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
PH12016502530A1 (en) Pharmaceutical compositions comprising dgla and use of same
MX2021007899A (es) Composiciones con inhibidor selectivo de la trans-se?alizacion de il-6.
MX2017006019A (es) Apilimod para uso en el tratamiento de melanoma.
MX2016008150A (es) Formulaciones de berberina y usos de las mismas.
CL2018001715A1 (es) Reguladores del cftr y métodos para su uso
CL2018001716A1 (es) Reguladores del cftr y métodos para su uso
EA032472B9 (ru) Композиция для укладки волос
MX2015016603A (es) Composiciones de corticosteroides.

Legal Events

Date Code Title Description
FG Grant or registration
PD Change of proprietorship

Owner name: PROPELLA THERAPEUTICS, INC.